Association between preoperative aspartate aminotransferase-to-platelet ratio index and prognosis in colorectal liver metastases: a systematic review and meta-analysis
Journal of Gastrointestinal Oncology · 2026-06 · 17 (3) · 158-158
DOI: 10.21037/jgo-2025-1-1069 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Gastrointestinal Oncology, 2026-06. Verfasst von Huiwen Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School, Hunan University of Chinese Medicine, Changsha, China. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Graduate School, Hunan University of Chinese Medicine, Changsha, China.
- Department of Proctology, Hunan Province Hospital of Integrated Chinese and Western Medicine, Changsha, China.
- Department of Anorectal, Second Affiliated Hospital of Hunan University of Chinese Medicine, Changsha, China.
Zitieren
APA
Li, H., Yin, Y., Yang, Z., Ding, N., & He, Y. (2026). Association between preoperative aspartate aminotransferase-to-platelet ratio index and prognosis in colorectal liver metastases: a systematic review and meta-analysis. Journal of Gastrointestinal Oncology, 17(3), 158-158. https://doi.org/10.21037/jgo-2025-1-1069
Vancouver
Li H, Yin Y, Yang Z, Ding N, He Y. Association between preoperative aspartate aminotransferase-to-platelet ratio index and prognosis in colorectal liver metastases: a systematic review and meta-analysis. Journal of Gastrointestinal Oncology. 2026;17(3):158-158. doi:10.21037/jgo-2025-1-1069
BibTeX
@article{Li2026,
author = {Li, Huiwen and Yin, Yuanyuan and Yang, Zongliang and Ding, Ning and He, Yongheng},
title = {Association between preoperative aspartate aminotransferase-to-platelet ratio index and prognosis in colorectal liver metastases: a systematic review and meta-analysis},
journal = {Journal of Gastrointestinal Oncology},
year = {2026},
volume = {17},
number = {3},
pages = {158--158},
doi = {10.21037/jgo-2025-1-1069}
}
EUVIMED